close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Avenacy

Avenacy to Highlight 2025 Achievements and Partnership Opportunities at CPHI Frankfurt
From Avenacy
Via Business Wire
Avenacy Announces Launch of Lidocaine Hydrochloride Injection, USP in the U.S. Market
From Avenacy
Via Business Wire
Avenacy Announces Launch of Dehydrated Alcohol Injection, USP Vials in the U.S. Market
From Avenacy
Via Business Wire
Avenacy Announces New Asset Based Lending Agreement with Texas Capital Bank
From Avenacy
Via Business Wire
Avenacy Announces Launch of Leuprolide Acetate Injection in the U.S. Market
From Avenacy
Via Business Wire
Avenacy Announces Launch of Doxycycline for Injection, USP in the U.S. Market
From Avenacy
Via Business Wire
Avenacy Announces Launch of Propofol Injectable Emulsion, USP in the U.S. Market
From Avenacy
Via Business Wire
Avenacy Announces Launch of Five Injectable Antibiotic Products in the U.S. Market
From Avenacy
Via Business Wire
Avenacy to Attend 2025 DCAT Week
From Avenacy
Via Business Wire
Avenacy Announces Launch of Zoledronic Acid Injection, USP in the U.S. Market
From Avenacy
Via Business Wire
Avenacy Provides Update on 2025 Strategic Priorities Ahead of 43rd Annual J.P. Morgan Healthcare Conference
From Avenacy
Via Business Wire
Avenacy to Attend J.P. Morgan 43rd Annual Healthcare Conference
From Avenacy
Via Business Wire
Avenacy to Attend 2024 ASHP Midyear Clinical Meeting and Exhibition
From Avenacy
Via Business Wire
Avenacy Announces Launch of Dexmedetomidine Injection, USP in the U.S. Market
From Avenacy
Via Business Wire
Avenacy to Share Company’s Year One Progress at CPHI Milan 2024
From Avenacy
Via Business Wire
Avenacy Announces Launch of Metoclopramide Injection, USP in the U.S. Market
From Avenacy
Via Business Wire
Avenacy Announces Dr. Patrick Soon-Shiong as Major Investor, Co-founder and Board Member
From Avenacy
Via Business Wire
Avenacy Announces Launch of Palonosetron Hydrochloride Injection, USP in the U.S. Market
From Avenacy
Via Business Wire
Avenacy Announces Launch of Prochlorperazine Edisylate Injection, USP in the U.S. Market
From Avenacy
Via Business Wire
Avenacy Announces Launch of Tranexamic Acid Injection, USP in the U.S. Market
From Avenacy
Via Business Wire
Avenacy Announces Launch of Isoproterenol Hydrochloride Injection, USP in the U.S. Market
From Avenacy
Via Business Wire
Avenacy Announces Launch of Magnesium Sulfate in Water for Injection in the U.S. Market
From Avenacy
Via Business Wire
Avenacy Announces Launch of Eptifibatide for Injection in the U.S. Market
From Avenacy
Via Business Wire
Avenacy Announces Launch of Desmopressin Acetate for Injection in the U.S. Market
From Avenacy
Via Business Wire
Avenacy Announces Launch of Furosemide for Injection in the U.S. Market
From Avenacy
Via Business Wire
Avenacy Announces New Product Launches and Participation in DCAT Week 2024
From Avenacy
Via Business Wire
Avenacy Announces Launch of Bivalirudin for Injection in the U.S. Market
From Avenacy
Via Business Wire
Avenacy Announces Launch of Melphalan Hydrochloride for Injection in the U.S. Market
From Avenacy
Via Business Wire
Avenacy to Attend 2023 ASHP Midyear Clinical Meeting and Exhibition
From Avenacy
Via Business Wire
Avenacy Launches to Deliver Critical Medications
From Avenacy
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today